Siyun H. Wang
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
PET/CT predict pathological response to neoadjuvant nivolumab in resectable non-small cell lung cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 24, 2025
PET/CT deep learning prognosis for treatment decision support in esophageal squamous cell carcinoma.
PET/CT deep learning prognosis for treatment decision support in esophageal squamous cell carcinoma.
Journal: Insights into imaging
Published: January 06, 2024
Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB-IV NSCLC (LCDigital-IO Study): a multicenter retrospective study.
Journal: Journal for immunotherapy of cancer
Published: September 18, 2023
Circ_0003028 enhances the proliferation and glycolytic capacity and suppresses apoptosis in non-small cell lung cancer cells via the miR-1305/miR-1322-SLC5A1 axis.
Journal: Annals of translational medicine
Published: December 14, 2022
PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: June 29, 2022
Clinical use of 18F-FDG PET/CT in the differential diagnosis of patients with primary and secondary adenoid cystic carcinoma of the lung: a retrospective cohort study.
Journal: Translational lung cancer research
Published: May 17, 2022
Bioinformatics identification of miR-514b-5p promotes NSCLC progression and induces PI3K/AKT and p38 pathways by targeting small glutamine-rich tetratricopeptide repeat-containing protein beta.
Journal: The FEBS journal
Published: April 11, 2022
Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer.
Journal: Clinical and translational medicine
Published: March 08, 2022
Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non-small cell lung cancer (NSCLC) via the PI3K/AKT pathway.
Journal: Thoracic cancer
Published: January 01, 2022
Methyltransferase-like 3 upregulation is involved in the chemoresistance of non-small cell lung cancer.
Journal: Annals of translational medicine
Published: November 08, 2021
Preoperative CT-based peritumoral and tumoral radiomic features prediction for tumor spread through air spaces in clinical stage I lung adenocarcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 20, 2021
Development and validation of a preoperative CT-based radiomic nomogram to predict pathology invasiveness in patients with a solitary pulmonary nodule: a machine learning approach, multicenter, diagnostic study.
Journal: European radiology
Published: October 20, 2020
Last Updated: 09/26/2026